Autorizzazione alla conduzione dello Studio “A non interventional observational retrospective post authorization study of relapsed and refractory Multiple Myeloma patients treated for least 24 months with Lenalidomide and Dexametasone”. Codice Protocollo: MM-LEN-DEX-2013.